Last update 21 Nov 2024

RG-002

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
FGFRs
Mechanism
FGFRs antagonists(Fibroblast growth factor receptors antagonists)
Therapeutic Areas
Neoplasms
Active Indication
Solid tumor
Inactive Indication
HIV Infections
Originator Organization
Questcor Pharmaceuticals, Inc.Questcor Pharmaceuticals, Inc.
Active Organization
Shanghai Lingda Biological Medicine Co., Ltd.Shanghai Lingda Biological Medicine Co., Ltd.
Inactive Organization
Questcor Pharmaceuticals, Inc.Questcor Pharmaceuticals, Inc.
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with RG-002
CTR20223339 / RecruitingPhase 1
评价RG002片在晚期实体瘤患者中的安全性、耐受性、药代动力学、药效动力学及初步有效性的单臂、开放、单/多次给药剂量递增及剂量扩展的I期临床研究
[Translation] A single-arm, open-label, single/multiple-dose dose-escalation and dose-expansion Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of RG002 tablets in patients with advanced solid tumors
100 Clinical Results associated with RG-002
Login to view more data
100 Translational Medicine associated with RG-002
Login to view more data
100 Patents (Medical) associated with RG-002
Login to view more data
2
Literatures (Medical) associated with RG-002
01 Oct 1999Journal of Pharmaceutical and Biomedical AnalysisQ3 · MEDICINE
Quantitative determination of ginsenosides from Panax ginseng roots and ginseng preparations by thin layer chromatography–densitometry
Q3 · MEDICINE
01 Aug 1987Zhong yao tong bao (Beijing, China : 1981)
[Isolation and identification of saponin IV, V, VI and VII in ginseng stems].
100 Deals associated with RG-002
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV InfectionsPhase 2
US
Questcor Pharmaceuticals, Inc.Questcor Pharmaceuticals, Inc.
-
Solid tumorPhase 1
CN
Shanghai Lingda Biological Medicine Co., Ltd.Shanghai Lingda Biological Medicine Co., Ltd.
23 Mar 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free